This announcement is a separate document:
复星医药：复星医药关于2022年度第一期中期票据发行完成的公告
Fosun Pharmaceutical: Fosun Pharmaceutical\'s announcement on the completion of the issuance of the first issue of 2022 interim notes
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.